Consolidating KMS-11 as our primary experimental model for investigating the role of p52 in multiple myeloma, we identified several p52-regulated essential genes upregulated in patients, i.e. RGS1 and RHEB, whose expression have been linked to poorer prognosis in MM patients and other cancers53,54. This evidence concerns the gene NFKB2 and plasma cell myeloma.